Allen Ho currently serves as the National Director of Field Medical for Ultra-Rare Medicines at Amgen, a position held since October 2023. Prior to this role, Allen Ho was with Alexion Pharmaceuticals, Inc. from April 2018 to September 2023, holding titles of Director, MSL Lead in Hematology/Nephrology, as well as Senior Medical Science Liaison in the same therapeutic areas. Allen Ho's earlier experience includes a tenure at Astellas Pharma US from 2009 to 2018, where roles included Senior Manager and Medical Science Liaison in Infectious Disease-Transplant. Allen Ho began a Post-Doctoral Fellowship at Rutgers University in July 2008, focusing on market research and competitive intelligence with Tibotec Therapeutics while also serving as Adjunct Faculty. Allen Ho earned a Doctor of Pharmacy degree (Pharm.D.) from the University of the Pacific between 2005 and 2008.
Org chart
This person is not in the org chart
Teams
This person is not in any teams
Offices
Amgen
252 followers
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
